Literature DB >> 20392920

Epidemiologic study of human influenza virus infection in South Korea from 1999 to 2007: origin and evolution of A/Fujian/411/2002-like strains.

Seokha Kang1, In Seok Yang, Joo-Yeon Lee, Yiho Park, Hee-Bok Oh, Chun Kang, Kyung Hyun Kim.   

Abstract

Influenza epidemics arise through the accumulation of viral genetic changes, culminating in a novel antigenic type that is able to escape host immunity. Following an outbreak of the A/Fujian/411/2002-like strains in Asia, including China, Japan, and South Korea, in 2002, Australia and New Zealand experienced substantial outbreaks of the same strains in 2003, and subsequently worldwide outbreaks occurred in the 2003-2004 season. The emergence of A/Fujian/411/2002-like strains coincided with a higher level of influenza-like illness in South Korea than what is seen at the peak of a normal season, and there was at least a year's difference between South Korea and the United States. Genetic evolution of human influenza A/H3N2 viruses was monitored by sequence analysis of hemagglutinin (HA) genes collected in Asia, including 269 (164 new) HA genes isolated in South Korea from 1999 to 2007. The Fujian-like influenza strains were disseminated with rapid sequence variation across the antigenic sites of the HA1 domain, which sharply distinguished between the A/Moscow/10/1999-like and A/Fujian/411/2002-like strains. This fast variation, equivalent to approximately 10 amino acid changes within a year, occurred in Asia and would be the main cause of the disappearance of the reassortants, although the reassortant and nonreassortant Fujian-like strains circulated simultaneously in Asia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20392920      PMCID: PMC2884524          DOI: 10.1128/JCM.00209-10

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Predicting the evolution of human influenza A.

Authors:  R M Bush; C A Bender; K Subbarao; N J Cox; W M Fitch
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

2.  Ecological and immunological determinants of influenza evolution.

Authors:  Neil M Ferguson; Alison P Galvani; Robin M Bush
Journal:  Nature       Date:  2003-03-27       Impact factor: 49.962

3.  The Wilhelmine E. Key 1999 Invitational lecture. Predicting the evolution of human influenza A.

Authors:  W M Fitch; R M Bush; C A Bender; K Subbarao; N J Cox
Journal:  J Hered       Date:  2000 May-Jun       Impact factor: 2.645

4.  A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood.

Authors:  Stéphane Guindon; Olivier Gascuel
Journal:  Syst Biol       Date:  2003-10       Impact factor: 15.683

5.  MUSCLE: multiple sequence alignment with high accuracy and high throughput.

Authors:  Robert C Edgar
Journal:  Nucleic Acids Res       Date:  2004-03-19       Impact factor: 16.971

6.  Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003.

Authors:  Terry G Besselaar; Lizelle Botha; Jo M McAnerney; Barry D Schoub
Journal:  J Med Virol       Date:  2004-05       Impact factor: 2.327

7.  Restriction of amino acid change in influenza A virus H3HA: comparison of amino acid changes observed in nature and in vitro.

Authors:  Katsuhisa Nakajima; Eri Nobusawa; Ken Tonegawa; Setsuko Nakajima
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 8.  Realities and enigmas of human viral influenza: pathogenesis, epidemiology and control.

Authors:  Maurice R Hilleman
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

9.  Recent human influenza A/H3N2 virus evolution driven by novel selection factors in addition to antigenic drift.

Authors:  Matthew J Memoli; Brett W Jagger; Vivien G Dugan; Li Qi; Jadon P Jackson; Jeffery K Taubenberger
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

10.  Mapping the antigenic and genetic evolution of influenza virus.

Authors:  Derek J Smith; Alan S Lapedes; Jan C de Jong; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2004-06-24       Impact factor: 47.728

View more
  7 in total

1.  Host contact structure is important for the recurrence of Influenza A.

Authors:  J M Jaramillo; Junling Ma; P van den Driessche; Sanling Yuan
Journal:  J Math Biol       Date:  2018-07-04       Impact factor: 2.259

2.  Effect of the H1N1 influenza pandemic on the incidence of epidemic keratoconjunctivitis and on hygiene behavior: a cross-sectional study.

Authors:  Hyun Su Kim; Ho Chun Choi; Belong Cho; Joon Yong Lee; Min Jeong Kwon
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

3.  Contribution of murine innate serum inhibitors toward interference within influenza virus immune assays.

Authors:  Kevin T Cwach; Heather R Sandbulte; Joshua M Klonoski; Victor C Huber
Journal:  Influenza Other Respir Viruses       Date:  2011-08-29       Impact factor: 4.380

4.  Molecular characterization of influenza viruses collected from young children in Uberlandia, Brazil - from 2001 to 2010.

Authors:  Thelma Fátima de Mattos Silva Oliveira; Jonny Yokosawa; Fernando Couto Motta; Marilda Mendonça Siqueira; Hélio Lopes da Silveira; Divina Aparecida Oliveira Queiróz
Journal:  BMC Infect Dis       Date:  2015-02-18       Impact factor: 3.090

5.  Exploring the molecular epidemiology and evolutionary dynamics of influenza A virus in Taiwan.

Authors:  Jih-Hui Lin; Shu-Chun Chiu; Yung-Cheng Lin; Ju-Chien Cheng; Ho-Sheng Wu; Marco Salemi; Hsin-Fu Liu
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

Review 6.  Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults.

Authors:  Theodore F Tsai
Journal:  Infect Chemother       Date:  2013-06-26

7.  Molecular epidemiology of influenza A/H3N2 viruses circulating in Mexico from 2003 to 2012.

Authors:  Marina Escalera-Zamudio; Martha I Nelson; Ana Georgina Cobián Güemes; Irma López-Martínez; Natividad Cruz-Ortiz; Miguel Iguala-Vidales; Elvia Rodríguez García; Gisela Barrera-Badillo; Jose Alberto Díaz-Quiñonez; Susana López; Carlos F Arias; Pavel Isa
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.